Nucleophilic halogenation reagents
亲核卤化试剂
基本信息
- 批准号:10058844
- 负责人:
- 金额:$ 29.26万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2016
- 资助国家:美国
- 起止时间:2016-12-06 至 2022-11-30
- 项目状态:已结题
- 来源:
- 关键词:AcidityAcidsAgrochemicalsAlkenesAmino AcidsBiologicalCationsChemicalsComplexCorrosivesDatabasesDescriptorEthersFluorineGenerationsGoalsGuidelinesHeterocyclic CompoundsHydrogenHydrogen BondingHydrogen FluorideIn SituLaboratoriesLiquid substanceMediatingMediator of activation proteinMetabolicMetalsMethodologyMethodsNaturePatternPeriodicityPharmaceutical ChemistryPharmaceutical PreparationsPreparationPropertyProtocols documentationReactionReagentResearchResistanceSolidSourceSpecial EquipmentSystemTemperatureTransition ElementsWorkalkalinitybasecase-by-case basiscatalystcyclic compounddesigndrug discoveryequipment traininghalogenationorganic basepyridinestereochemistrytriethylaminevirtual
项目摘要
Project Summary
Most, if not all, fluorinating reagents (electrophilic or nucleophilic) are actually made from
hydrogen fluoride (HF). However, the gaseous and corrosive nature of HF excludes it from
working laboratories where special equipment and training are not available. The complexes of
HF with organic bases like pyridine-HF complex (Olah's reagent) and triethylamine-HF complex
have been explored extensively as nucleophilic sources of fluorine, but use of these organic
bases reduce the acidity of the system and may interfere with many metal catalysts. So far there
is no HF-based nucleophilic fluorination reagent that works well in acid or transition metal
catalyzed reactions. Our primary goal is to develop a new generation of HF-based nucleophilic
fluorination reagents that is compatible with acids and metal catalysts based on a rational
design. The same strategy can also be used for new HX (X = Cl, Br, I)-based halogenation
reagents.
Hydrogen bonding, rather than an ionic interaction, has been identified as the major interaction
between HF and an organic base in complexes such as pyridine-HF (Olah's reagent). To reduce
the volatility of an HF complex (make it a liquid or solid at room temperature), we have to use a
relatively good hydrogen bonding acceptor (HBA) to complex with HF. Our hypothesis is: a
strong (good) hydrogen bonding acceptor is not necessarily a strong base (BrØnsted or
Lewis base). In this way, a compound that serves as good hydrogen bonding acceptor (better
than pyridine or triethylamine), but is less basic, is expected to form a less volatile complex. And
due to the low basicity of this HBA, the resulting HBA-HF complex will be compatible with acid
catalysts or mediators. In this manner, we may achieve unprecedented reactivity and selectivity
in HF-participating reactions.
The first part of our research is the preparation of HBA-HX complexes. We are seeking
`anomaly' HBAs, that is, good hydrogen bond acceptors but weak BrØnsted bases. The
quantitative descriptor of hydrogen bond basicity and BrØnsted basicity shown in Figure 1
(based on Laurence and co-workers' database of hydrogen-bond basicity) is our primary
guideline for the selection of suitable hydrogen bonding acceptors.
The nucleophilic fluorination reagents proposed and the methodologies for their use will enable
diverse-oriented, stereo- and regio-selective synthesis of fluoroamines, fluorohydrins,
fluoroaminoacids, fluorinated aliphatic, alkenes, cyclic and heterocyclic compounds, through
new synthetic protocols such as tandem HF-addition-metathesis, HF trapping in cationic
cascade reactions, strain-release nucleophilic fluorinations, in-situ electrophilic fluorine
formation, Markovnikov and anti-Markovnikov hydrofluorinations. A similar strategy will be used
to develop designer-HX based (X = Cl, Br, I) halogenation reagents.
One of our reagents (DMPU-HF) is already commercially available, and we will commercialize
other newly developed reagents to make our methods available to medicinal chemists
worldwide.
项目摘要
实际上,大多数(如果不是全部),实际上是由
氟化氢(HF)。但是,HF的气态和腐蚀性将其排除在外
没有特殊设备和培训的工作实验室。综合体
HF具有有机碱,例如吡啶-HF复合物(OLAH的试剂)和三乙胺-HF复合物
已被广泛探索为氟的核螺旋来源,但使用这些有机物
碱会降低系统的酸度,并可能干扰许多金属催化剂。到目前为止
不是基于HF的核氟化试剂,它在酸或过渡金属中效果很好
催化反应。我们的主要目标是开发新一代的基于HF的核系统
氟化试剂与酸和金属催化剂兼容,基于有理
设计。基于新的HX(X = CL,BR,I)的卤素也可以使用相同的策略
试剂。
氢键而不是离子相互作用已被确定为主要相互作用
在吡啶-HF(OLAH的试剂)等复合物中的HF和有机碱之间。减少
HF复合物的挥发性(使其成为液体或在室温下固体),我们必须使用
与HF复合物相关的良好氢键受体(HBA)。我们的假设是:
强(良好的)氢键受体不需要坚固的基础(Brønsted或
刘易斯基地)。这样,可以用作良好氢键受体的化合物(更好
比吡啶或三乙胺),但预期较低的碱性将形成挥发性较小的复合物。和
由于该HBA的碱性低,所得的HBA-HF复合物将与酸兼容
催化剂或介体。通过这种方式,我们可以实现前所未有的反应性和选择性
在HF参与反应中。
我们研究的第一部分是制备HBA-HX复合物。我们正在寻找
“异常” HBA,即良好的氢键受体,但Brønsted碱基弱。这
氢键碱度和Brønsted碱度的定量描述如图1所示
(基于劳伦斯和同事的氢键基础数据库)是我们的主要
选择合适的氢键受体的指南。
提出的核氟化试剂和使用的方法将实现
氟胺,氟氢蛋白,氟胺的立体和区域选择性合成,立体和区域选择性合成
通过氟氨基酸,氟脂肪族,烷烃,环状和杂环化合物通过
新的合成协议,例如串联HF-ADDITION-METASESIS,HF捕获在阳离子中
级联反应,应变释放核荧光,原位亲电荧光素
Markovnikov和抗Markovnikov氢氟化。将使用类似的策略
开发基于设计的HX(X = Cl,BR,I)卤素化试剂。
我们的试剂之一(DMPU-HF)已经在商业上可用,我们将商业化
其他新开发的试剂使我们的方法可用于药物化学家
全世界。
项目成果
期刊论文数量(20)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Metal-Free and User-Friendly Regioselective Hydroxyfluorination of Olefins.
- DOI:10.1021/acs.orglett.8b00681
- 发表时间:2018-04-20
- 期刊:
- 影响因子:5.2
- 作者:Sedgwick DM;López I;Román R;Kobayashi N;Okoromoba OE;Xu B;Hammond GB;Barrio P;Fustero S
- 通讯作者:Fustero S
Chloride-Tolerant Gold(I)-Catalyzed Regioselective Hydrochlorination of Alkynes.
耐氯化物金 (I) 催化的炔烃区域选择性氢氯化反应
- DOI:10.1021/acscatal.7b02567
- 发表时间:2017-10-06
- 期刊:
- 影响因子:12.9
- 作者:Ebule R;Liang S;Hammond GB;Xu B
- 通讯作者:Xu B
Practical Synthesis of α-Trifluoromethylated Pyridines Based on Regioselective Cobalt-Catalyzed [2+2+2] Cycloaddition using Trifluoromethylated Diynes with Nitriles.
- DOI:10.1002/adsc.202001433
- 发表时间:2021-03-29
- 期刊:
- 影响因子:5.4
- 作者:Kumon T;Yamada S;Agou T;Fukumoto H;Kubota T;Hammond GB;Konno T
- 通讯作者:Konno T
HCl•DMPU-Assisted One-pot and Metal-free Conversion of Aldehydes to Nitriles.
- DOI:10.1039/d0gc00757a
- 发表时间:2020-07-07
- 期刊:
- 影响因子:0
- 作者:Mudshinge SR;Potnis CS;Xu B;Hammond GB
- 通讯作者:Hammond GB
Synthesis and applications of S-(trifluoromethyl)-2,8-bis(trifluoromethoxy)dibenzothiophenium triflate (Umemoto reagent IV).
- DOI:10.1016/j.jfluchem.2022.110015
- 发表时间:2022-07
- 期刊:
- 影响因子:1.9
- 作者:Sagar R. Mudshinge;G. Hammond;T. Umemoto
- 通讯作者:Sagar R. Mudshinge;G. Hammond;T. Umemoto
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
GERALD B HAMMOND其他文献
GERALD B HAMMOND的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('GERALD B HAMMOND', 18)}}的其他基金
Transition metal catalyzed construction of ring systems
过渡金属催化构建环系
- 批准号:
8290765 - 财政年份:2012
- 资助金额:
$ 29.26万 - 项目类别:
WOUND HEALING ACCELERATION USING NATURAL PRODUCTS
使用天然产品加速伤口愈合
- 批准号:
2810705 - 财政年份:1999
- 资助金额:
$ 29.26万 - 项目类别:
ISOLATION OF BIOACTIVE COMPOUNDS FROM PERUVIAN PLANTS
从秘鲁植物中分离生物活性化合物
- 批准号:
2097683 - 财政年份:1993
- 资助金额:
$ 29.26万 - 项目类别:
相似国自然基金
阿魏酸基天然抗氧化抗炎纳米药物用于急性肾损伤诊疗一体化研究
- 批准号:82302281
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
深层碳酸盐岩酸蚀裂缝中反应-非线性两相流界面演化机制研究
- 批准号:52304047
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
核苷酸代谢酶氧化修饰调控上皮干细胞命运在口腔白斑病光动力治疗复发中的机制与意义研究
- 批准号:82330029
- 批准年份:2023
- 资助金额:220 万元
- 项目类别:重点项目
RNF31通过厚壁菌代谢产物3-氧代胆碱酸调控RORγ信号轴抑制Th17细胞分化—溃疡性结肠炎干预新靶点
- 批准号:82360112
- 批准年份:2023
- 资助金额:32 万元
- 项目类别:地区科学基金项目
氨基酸转运体调控非酒精性脂肪肝的模型建立及机制研究
- 批准号:32371222
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
相似海外基金
Biosynthesis of Several Oxyvinylglycine Nonproteinogenic Amino Acids Bearing Unusual Alkoxyamine Bonds
几种带有异常烷氧基胺键的氧乙烯甘氨酸非蛋白氨基酸的生物合成
- 批准号:
10752052 - 财政年份:2023
- 资助金额:
$ 29.26万 - 项目类别:
Metal-Mediated C-H Radiofluorination for Rapid Access to PET Imaging Agents
金属介导的 C-H 放射性氟化用于快速获得 PET 成像剂
- 批准号:
10369752 - 财政年份:2022
- 资助金额:
$ 29.26万 - 项目类别:
Metal-Mediated C-H Radiofluorination for Rapid Access to PET Imaging Agents
金属介导的 C-H 放射性氟化用于快速获得 PET 成像剂
- 批准号:
10615600 - 财政年份:2022
- 资助金额:
$ 29.26万 - 项目类别:
Organobismuth Compounds As Universal Precursors for Oxidative and Reductive Radical Group Transfer via Photoredox Catalysis
有机铋化合物作为通过光氧化还原催化进行氧化和还原基团转移的通用前体
- 批准号:
10231424 - 财政年份:2021
- 资助金额:
$ 29.26万 - 项目类别:
Organobismuth Compounds As Universal Precursors for Oxidative and Reductive Radical Group Transfer via Photoredox Catalysis
有机铋化合物作为通过光氧化还原催化进行氧化和还原基团转移的通用前体
- 批准号:
10463570 - 财政年份:2021
- 资助金额:
$ 29.26万 - 项目类别: